# FDA 483 - Nephron Pharmaceuticals - December 02, 2022

Source: https://www.globalkeysolutions.net/records/483/nephron-pharmaceuticals/9a4c329f-4c1e-4f51-a19e-b282e83129f2

> FDA 483 for Nephron Pharmaceuticals on December 02, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Nephron Pharmaceuticals
- Inspection Date: 2022-12-02
- Product Type: Drugs
- Office Name: Cincinnati District Office

## Related Officers

- [Investigator?](https://www.globalkeysolutions.net/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)
- [Investigator ](https://www.globalkeysolutions.net/people/logan-t-williams/a1febf59-970a-4e4e-9c0c-f4ad385582d7)

Company: https://www.globalkeysolutions.net/companies/nephron-pharmaceuticals/534f25ab-b6d3-49dc-b414-b910d3c66a0b

Office: https://www.globalkeysolutions.net/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22